BTK Inhibitors Continue to Offer Chemotherapy-Free Options for MCL Treatment
The use of Bruton’s tyrosine kinase (BTK) inhibitors have grown dramatically in the field of mantle cell lymphoma (MCL), providing a chemotherapy-free option for many...
Pembrolizumab Shows Improvements in Disease-Free Survival as Adjuvant Treatment for Non-Small Cell Lung Cancer
The findings from the phase 3 KEYNOTE-091 trial mark the first positive study for pembrolizumab in adjuvant stage IB-IIIA non-small cell lung cancer.New study results...